Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:13 PM ET 8-K
Stock Plan Amendment Mobility Global Inc. MBGL

Mobility Global Stock Plan Amendment

Mobility Global Inc. approved one-time restricted stock unit (RSU) awards for Scott Fredericks, President of CARFAX, and Joseph S. LaFeir, President of Mobility Business Solutions. The awards, valued at $1.25 million and $1.0 million respectively, will be granted on December 1, 2026, and vest in three equal annual installments.

Term
3 years
4:12 PM ET 8-K
Capital Raise Arcus Biosciences, Inc. RCUS

Arcus Biosciences Capital Raise of $288M

Arcus Biosciences completed a public offering of 16,428,572 shares of common stock, including the full exercise of the underwriters' option to purchase additional shares. The offering was priced at $17.50 per share, resulting in net proceeds of approximately $269.7 million after fees and expenses.

Value
$288M
Counterparty
Jefferies LLC, Leerink Partners LLC and TD Securities (USA) LLC
4:10 PM ET 8-K
Nasdaq/NYSE Compliance Notice Citius Oncology, Inc. CTOR

Citius Oncology Nasdaq/NYSE Compliance Notice

Citius Oncology received a formal extension from Nasdaq until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. To satisfy the rule, the company's common stock must close at or above $1.00 for at least ten consecutive business days. The stock continues to trade on the Nasdaq Capital Market under the symbol 'CTOR' while the company evaluates options to address the deficiency.

Counterparty
Nasdaq Stock Market LLC
Term
through April 19, 2027
4:10 PM ET 8-K
M&A Deal Melar Acquisition Corp. I MACI

Melar Acquisition Corp. I M&A Deal with Everli Global Inc.

Melar Acquisition Corp. I shareholders approved its proposed business combination with Everli Global Inc., an e-grocery technology and fulfillment platform in Italy. Following the closing, the combined company will operate as Everli Global Holdings Inc. and trade on Nasdaq under the ticker 'EVRL'.

Counterparty
Everli Global Inc.
4:10 PM ET Form 4
Insider Selling Travelers Companies, Inc. TRV

Travelers Companies Chairman and CEO Alan D. Schnitzer Sells $35.3M of Stock

Alan D. Schnitzer, Chairman and CEO, sold 88,900 shares of Travelers Companies, Inc. at $394.80 to $398.20 a share (average $396.77) in 5 transactions, worth $35.3M in total on Oct 21, 2026. Shares held after the trade: 303,124 (-1.0%).

Value
$35.3M
Shares
88,900
Average price
$396.77
Role
Chairman and CEO
Holding change
-1.0%
Trade date
Oct 21, 2026
4:10 PM ET 8-K
Divestiture Jewett Cameron Trading Co Ltd JCTC

Jewett Cameron Trading Co Divestiture to Washington County for $5.9M

Jewett-Cameron Trading Company's subsidiary, JC USA Inc., entered into a definitive agreement to sell its surplus seed property in Hillsboro, Oregon, to Washington County for $5.9 million. The transaction is subject to a 180-day due diligence period and approval by the Washington County Board of Commissioners. Proceeds from the sale will be used to reduce any outstanding amounts under the company's credit facility, though no amounts are currently outstanding.

Value
$5.9M
Counterparty
Washington County
4:10 PM ET 10-Q
Financial Results Las Vegas Sands Corp LVS

Las Vegas Sands Q3 2026 Results: Net Income $304M, Down 27.4% YoY

Las Vegas Sands Corp. reported net revenues of $3.22 billion for the third quarter of 2026, a slight decrease from $3.33 billion in the prior year period. Despite the revenue dip, the company maintained strong liquidity with $2.86 billion in cash, though it recorded a total equity deficit of $115 million as of September 30, 2026, primarily due to significant treasury stock repurchases.

Key figure
Net income $304M · -27.4% YoY
4:09 PM ET Form 4
Insider Selling Travelers Companies, Inc. TRV

Travelers Companies EVP & President, Business Ins. Gregory C. Toczydlowski Sells $14M of Stock

Gregory C. Toczydlowski, EVP & President, Business Ins., sold 34,771 shares of Travelers Companies, Inc. at $403.86 to $404.43 a share (average $403.89) in 2 transactions, worth $14M in total on Oct 22, 2026. Shares held after the trade: 18,416 (-10.2%).

Value
$14M
Shares
34,771
Average price
$403.89
Role
EVP & President, Business Ins.
Holding change
-10.2%
Trade date
Oct 22, 2026
4:09 PM ET 8-K
Loan & Debt PNC Financial Services Group, Inc. PNC

PNC Financial Services Group $1.5B Debt Financing with PNC Capital Markets LLC

The PNC Financial Services Group, Inc. completed a public offering of $1.5 billion in senior notes, consisting of $1.2 billion in 5.463% fixed-to-floating rate notes and $300 million in floating rate notes, both due in 2029. The notes were issued under an existing indenture with The Bank of New York Mellon acting as trustee to manage the company's debt obligations.

Value
$1.5B
Counterparty
PNC Capital Markets LLC, Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC
Term
3 years
4:09 PM ET 8-K
Shareholder Meeting Sachem Capital Corp. SACH

Sachem Capital Shareholder Meeting

Sachem Capital Corp. held its 2026 Annual Meeting of Shareholders on October 22, 2026. Shareholders elected three incumbent directors, ratified the appointment of Baker Tilly US, LLP as independent auditors for the 2026 fiscal year, and approved a non-binding advisory resolution on executive compensation.

4:09 PM ET Form 4
Insider Buying Rent the Runway, Inc. RENT

Rent the Runway Insider Nexus Capital Management LP Buys $2.25M of Stock

Nexus Capital Management LP bought 632,922 shares of Rent the Runway, Inc. at $3.55 a share, worth $2.25M in total on Oct 21, 2026. Shares held after the trade: 4,907,316 (+14.8%).

Value
$2.25M
Shares
632,922
Price
$3.55
Holding change
+14.8%
Trade date
Oct 21, 2026
4:08 PM ET 8-K
Dividend Cedar Realty Trust, Inc. CDR-PB

Cedar Realty Trust Dividend

Cedar Realty Trust's Board of Directors declared quarterly cash dividends for its Series B and Series C Cumulative Redeemable Preferred Stock. The dividends of $0.453125 and $0.40625 per share, respectively, are payable on November 20, 2026, to shareholders of record as of November 10, 2026.

4:08 PM ET 8-K
M&A Deal Novagold Resources Inc NG

Novagold Resources M&A Deal with Paulson Advisers LLC

NOVAGOLD provided a status update on its pending acquisition of the remaining 40% interest in Donlin Gold LLC from Paulson Advisers LLC. The company issued supplemental disclosures to its proxy statement to address demand letters from purported shareholders and avoid potential litigation delays ahead of the November 3, 2026, shareholder vote. Upon completion, NOVAGOLD will increase its ownership in Donlin Gold from 60% to 100% in an all-share transaction.

Counterparty
Paulson Advisers LLC
4:08 PM ET 8-K
Executive Compensation Lumen Technologies, Inc. LUMN

Lumen Technologies Executive Compensation

Lumen Technologies adopted a new Executive Severance Plan to streamline and consolidate its severance arrangements for senior leadership, including CEO Kate Johnson. The new plan replaces individual change of control agreements and the prior plan while maintaining substantially the same benefits, such as cash severance of 52 weeks' base salary for non-change-in-control terminations and two times salary plus bonus for terminations related to a change in control.

4:08 PM ET 10-Q
Financial Results QuantumScape Corp QS

QuantumScape Q3 2026 Results: Net Loss of $84.5M, Loss Narrows

QuantumScape reported a net loss of $84.5 million for the third quarter of 2026, an improvement from the $105.8 million loss in the same period of 2025. The company maintained a strong liquidity position with $819.8 million in cash, cash equivalents, and marketable securities, while continuing to invest heavily in research and development for its battery technology.

Key figure
Net loss $84.5M
4:08 PM ET 8-K
Leadership Change BuzzFeed, Inc. BZFD

BuzzFeed Leadership Change

David Arroyo has resigned as Chief Legal Officer and Corporate Secretary of BuzzFeed, Inc., effective November 6, 2026. His responsibilities will be absorbed by the existing legal team while the company searches for a replacement. The resignation was not due to any disagreements with the company's operations or policies.

4:08 PM ET Form 4
Insider Buying Rent the Runway, Inc. RENT

Rent the Runway Insider CHS US Investments LLC Buys $1.63M of Stock

CHS US Investments LLC bought 458,245 shares of Rent the Runway, Inc. at $3.55 a share, worth $1.63M in total on Oct 21, 2026. Shares held after the trade: 22,937,292 (+2.0%).

Value
$1.63M
Shares
458,245
Price
$3.55
Holding change
+2.0%
Trade date
Oct 21, 2026
4:08 PM ET 8-K
M&A Deal Sunrise Realty Trust, Inc. SUNS

Sunrise Realty Trust M&A Deal with Southern Realty Trust Inc.

Sunrise Realty Trust stockholders approved the issuance of approximately 8.46 million shares for its pending merger with Southern Realty Trust Inc. The merger, which has now received approval from both companies' stockholders, is expected to close on November 5, 2026, creating a larger Nasdaq-listed commercial real estate lending platform.

Counterparty
Southern Realty Trust Inc.
4:07 PM ET 8-K
Nasdaq/NYSE Compliance Notice Stem, Inc. STEM

Stem Nasdaq/NYSE Compliance Notice

Stem, Inc. received a non-compliance letter from the NYSE because its average global market capitalization and stockholders' equity both fell below the $50 million minimum requirement over a 30 trading-day period. The company intends to submit a business plan within 45 days detailing how it will regain compliance within the 18-month cure period. The company's common stock will continue to trade on the NYSE during this period, subject to the exchange's acceptance of the plan.

Counterparty
New York Stock Exchange
Term
18 months
4:07 PM ET 8-K
Leadership Change Dole plc DOLE

Dole Leadership Change

Ms. Helen Nolan, a Non-Executive Director of Dole plc, has informed the company of her intention to retire from the Board of Directors effective December 31, 2026. Ms. Nolan has served on the board since 2021, and her departure appears to be a planned retirement.

4:06 PM ET 8-K
Nasdaq/NYSE Compliance Notice Akebia Therapeutics, Inc. AKBA

Akebia Therapeutics Nasdaq/NYSE Compliance Notice

Akebia Therapeutics received a deficiency notice from Nasdaq because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 19, 2027, to regain compliance, which requires the stock to close at $1.00 or higher for at least 10 consecutive business days. Akebia is evaluating options to cure the deficiency, including a potential reverse stock split.

Counterparty
Nasdaq
Term
180 days
4:06 PM ET 8-K
Clinical Trial Data Macrogenics Inc MGNX

Macrogenics Clinical Trial Data

MacroGenics announced positive interim Phase 1 data for MGC026, a B7-H3-directed antibody-drug conjugate, in patients with advanced solid tumors. The study showed a 27% best overall response rate in heavily pretreated SCCHN patients and a manageable safety profile with no treatment-related discontinuations in that cohort. Based on these results, the company plans to initiate a front-line combination study evaluating MGC026 with pembrolizumab.

4:06 PM ET 8-K
Loan & Debt Marvell Technology, Inc. MRVL

Marvell Technology $3B Debt Financing with Bank of America, N.A.

Marvell Technology entered into a $3 billion Third Amended and Restated Revolving Credit Agreement, doubling its previous $1.5 billion facility. The new agreement matures in October 2031 and includes an accordion feature allowing for an additional $2 billion in commitments. Proceeds will be used for working capital and general corporate purposes.

Value
$3B
Counterparty
Bank of America, N.A.
Term
5 years
4:06 PM ET 8-K
Nasdaq/NYSE Compliance Notice Polar Power, Inc. POLA

Polar Power Nasdaq/NYSE Compliance Notice

Polar Power, Inc. is providing an update on its efforts to regain compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million. The company has until October 28, 2026, to demonstrate compliance and has executed several financings, including convertible notes and Series A Preferred Stock issuances, to bolster its equity position. These transactions, along with an equity line of credit with Roth Principal Investments, are intended to meet the Nasdaq Capital Market's continued listing standards.

Counterparty
Nasdaq
Term
through Oct 28, 2026
4:06 PM ET 8-K
Leadership Change Hormel Foods Corp HRL

Hormel Foods Leadership Change

Sally J. Smith has notified Hormel Foods Corporation of her decision to retire from the Board of Directors, effective at the 2027 Annual Meeting of Stockholders. She will not stand for re-election, and the company stated her departure is not due to any disagreement.

4:06 PM ET 8-K
Other 8-K Filing Aptevo Therapeutics Inc. APVO

Aptevo Therapeutics Other 8-K Filing

Aptevo Therapeutics entered into Amendment No. 6 to its Rights Agreement, extending the expiration date of its shareholder rights plan (poison pill) to October 23, 2027. The amendment also adjusted the purchase price for the contingent preferred stock rights to $14.56 per one one-thousandth of a share.

Counterparty
Broadridge Corporate Issuer Solutions, LLC
Term
through Oct 2027
4:06 PM ET 8-K
Dividend Blue Owl Technology Income Corp. OTIC

Blue Owl Technology Income Dividend

Blue Owl Technology Income Corp. declared monthly distributions for its Class S, D, and I shares at a gross rate of $0.074775 per share, payable by November 30, 2026. The company also disclosed the sale of 505,374 unregistered Class I shares for approximately $4.98 million and reported a total net asset value of $2.6 billion as of September 30, 2026.

4:06 PM ET Form 4
Insider Selling Agios Pharmaceuticals, Inc. AGIO

Agios Pharmaceuticals CMO Sarah Gheuens Sells $74.6K of Stock

Sarah Gheuens, CMO, sold 1,989 shares of Agios Pharmaceuticals, Inc. at $37.52 to $37.53 a share (average $37.53) in 2 transactions, worth $74.6K in total between Oct 21, 2026 and Oct 22, 2026. Shares held after the trade: 54,645 (-0.9%).

Value
$74.6K
Shares
1,989
Average price
$37.53
Role
CMO
Holding change
-0.9%
Trade date
Oct 21, 2026 to Oct 22, 2026
4:06 PM ET 8-K
Product Launch High Roller Technologies, Inc. ROLR

High Roller Technologies Product Launch

High Roller Technologies has commercially launched ROLR™, its real-money prediction markets platform, for eligible U.S. customers following a successful beta period. The platform offers event-based contracts through a partnership with Crypto.com | Derivatives North America (CDNA) and is expected to begin generating revenue in Q4 2026.

Counterparty
Crypto.com | Derivatives North America

“Today’s full commercial launch of our prediction markets platform is a defining milestone for High Roller as we bring ROLR to the public and begin the next phase of our growth.”

Seth Young, Chief Executive Officer of High Roller Technologies

“Our goal is to make prediction markets accessible and engaging through an intuitive customer experience, and our experience operating real-money consumer platforms provides a strong foundation for building this business.”

Seth Young, Chief Executive Officer of High Roller Technologies
4:06 PM ET 8-K/A
M&A Deal Amneal Pharmaceuticals, Inc. AMRX

Amneal Pharmaceuticals M&A Deal with Kashiv BioSciences, LLC

Amneal Pharmaceuticals filed an amendment to its previous 8-K to provide required historical financial statements and pro forma financial information following its completed acquisition of Kashiv BioSciences, LLC. The acquisition was originally completed on August 10, 2026, pursuant to a Membership Interest Purchase Agreement dated April 21, 2026.

Counterparty
Kashiv BioSciences, LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.